Anticancer agent 253
Anticancer agent 253 (Compound 26) has anti-cancer activity against breast cancer cells, with IC50s of 6 μM (MCF-7), 10 μM (MDA-MB-231) and 6.4 μM (4T1 cells) . Anticancer agent 253 arrests cell cycle and induces mitochondria-mediated apoptosis in cancer cells. Anticancer agent 253 inhibits Akt phosphorylation in human breast and prostate cancer[1].
Product Specifications
CAS Number
[1983924-33-9]
UNSPSC
12352005
Target
Akt; Apoptosis
Type
Reference compound
Related Pathways
Apoptosis; PI3K/Akt/mTOR
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/anticancer-agent-253.html
Smiles
O=C(/C(CN(C/1)CC2=CN(N=N2)CC3=CC=C(C=C3)F)=C/C4=C(C=CC=C4)F)C1=C\C5=C(C=CC=C5)F
Molecular Formula
C29H23F3N4O
Molecular Weight
500.51
References & Citations
[1]Mandalapu D, et al. Synthesis and biological evaluation of some novel triazole hybrids of curcumin mimics and their selective anticancer activity against breast and prostate cancer cell lines. Bioorg Med Chem Lett. 2016 Sep 1;26 (17) :4223-32.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7092371 Inquire
Recombinant Mouse ADP-ribosylation factor-like protein 6-interacting protein 6 (Arl6ip6), partial
Ask
View Details 
MBS7187415 Inquire
Rabbit anti-Schizosaccharomyces pombe (strain 972/24843)(Fission yeast) SPAC5H10.03 Polyclonal Antibody
Ask
View Details MBS1105957-01 0.02 mg (E-Coli)
Recombinant Synechocystis sp. Probable aromatic acid decarboxylase (slr1099)
Ask
View Details 
MBS1105957-02 0.1 mg (E-Coli)
Recombinant Synechocystis sp. Probable aromatic acid decarboxylase (slr1099)
Ask
View Details 
MBS1105957-03 0.02 mg (Yeast)
Recombinant Synechocystis sp. Probable aromatic acid decarboxylase (slr1099)
Ask
View Details